AfternsAfterns
Up or down this time?Oct 29 scheduled
0%0%

···

Gilead Sciences Inc. (GILD) earnings date & stock reaction

Gilead Sciences Inc. · Healthcare

Gilead Sciences Inc. earnings date & time

Next earningsThu, October 29 around 4:00 PM ET, after the closescheduled

Schedule

Korea time (KST)
Fri, October 30
Reporting pattern
12 of last 12 after close
Typical move
±3.9% · 12-report avg

What the market expects

Consensus EPS

$2.15Coming in above this counts as a beat

Year-ago quarter
$2.47→-13.0%
Full earnings calendarFrom an earnings calendar

Price after the latest report

Reported August 4, 2026how the stock moved around it
Next-day move
-2.6%
After 5 days
+0.4%
Price around earnings

Gilead Sciences Inc. (GILD) rose the day after earnings in 6 of its last 12 reports (50%), moving ±3.9% on average. It has fallen despite beating the consensus estimate 5 times.

Up next day
6/12
50%
Fell despite growth
5/12
Good earnings ignored
Price when beating
+1.5%
avg over 11 beats
Price when missing
-4.2%
avg over 1 misses
Avg earnings move
±3.9%
typical swing on earnings
Biggest single move
+8.3%
'25.8 · largest reaction
🔑What actually moves this stock?

Even when EPS beat expectations, the stock fell 5 of the last 11 times. The number alone doesn't move it.

What really matters here
Blockbuster drug sales and the company's next-year outlook
In finance terms: Key drug sales · guidance
Growth · revenue (YoY by quarter, latest right)
+0%
25-04(Mar qtr)
+2%
25-08(Jun qtr)
+3%
25-10(Sep qtr)
+5%
26-02(Dec qtr)
+4%
26-05(Mar qtr)
+10%
26-08(Jun qtr)
Accelerating · Growth is accelerating (+0%→+10%), but this stock often falls even on strong results (5 recent times). Expectations are already high, so accelerating isn't enough. It must beat a lofty bar.
What to watch next report

When results drop, skip the EPS number. Check if the growth above holds or accelerates, and whether guidance beats expectations.

The real bar for this stock

Beating estimates isn't enough. Here's where the real surprise started.

Beat consensus 11 of 12 times. Beating is the default here
Median beat +11.7%. 5 of those beats still fell the next day.
Reports that rose beat by +13.1% (median). Reports that fell beat by just +6.9%
Roughly +13.1% was the bar this stock had to clear.

How this stock reacts to earnings

Traits seen across its recent earnings reactions

Beating estimates doesn't always lift it
Up the next day 6 of 11 beats (55%)
Big earnings-day moves tend to fade within days
Reversed the day-one move · 67% of last 12
vs Healthcare sector avg (155 peers)
This
+1.0%
Sector
+0.5%
Avg next-day reaction

Earnings number vs guidance: which drives it?

How often the beat/miss matched the actual price move

The number and guidance move the price about equally
Moved opposite to results 5 of last 12 times (42%)
5xBeat but fell
Even a beat sells off if guidance disappoints
0xMissed but rose
Even a miss rebounds if guidance reassures
Fell despite growth5/12

5/11 beats fell next day · watches Key drug sales · guidance

Next-day reaction
  • Jun 2026 report-2.6%
  • Mar 2026 report-2.0%
  • Dec 2025 report+5.8%
  • Sep 2025 report+1.1%
  • Jun 2025 report+8.3%
  • Mar 2025 report-2.8%

Earnings timeline · bars = next-day move, ▲▼ = beat/miss

Apr–Jun 2026 results
Reported 2026-08-04
Next-day move
-2.6%
After 5 days +0.4%
EPS consensus -$7.25 → -$6.75 ▲ +6.9% beatRev $7.1B → $7.8B +10% YoY
Beat by +6.9% but stock -2.6%
Price around earnings

Earnings trend · last 12 quarters

EPS$-6.75YoY -436%
'23.11'26.8
Revenue$7.8BYoY +10%
'23.11'26.8

Earnings history and price reaction

Gilead Sciences Inc. across its last 12 earnings reports: EPS versus consensus, the move on the earnings day, and the cumulative move five trading days later.
Quarter endedReported (ET)vs market expectation (consensus)Earnings dayAfter 5 days
6/20262026-08-04+6.9%-2.6%+0.4%
3/20262026-05-07+6.2%-2.0%-1.5%
12/20252026-02-10+2.8%+5.8%+3.7%
9/20252025-10-30+15.7%+1.1%+4.2%
6/20252025-08-07+2.7%+8.3%+7.9%
3/20252025-04-24+1.9%-2.8%-2.7%

12 reports, quarters ending 9/2023 to 6/2026. The earnings-day move is the first trading day that reflects the report; the five-day figure is the cumulative move from that point.

Frequently asked questions

When is the next Gilead Sciences Inc. earnings date?

The next Gilead Sciences Inc. (GILD) earnings report is expected Thu, October 29 around 4:00 PM ET, after the close. It comes from an earnings calendar and may not be a company-confirmed date; it updates automatically if it changes.

What is the consensus EPS forecast for Gilead Sciences Inc.'s next earnings?

Analysts expect EPS of about $2.15 for Gilead Sciences Inc. (GILD). Coming in above that counts as a beat, below it a miss — though a beat does not guarantee the stock rises.

Does Gilead Sciences Inc. (GILD) stock usually go up after earnings?

Over the last 12 earnings reports, the stock rose on 6 of them (50%). The average move on earnings day was ±3.9%.

Does Gilead Sciences Inc. react more to the earnings numbers or to guidance?

In 5 of the last 12 reports (42%), the stock moved the opposite way from whether it beat or missed the forecast. A high share means guidance and expectations drive the move more than the reported numbers.

Can Gilead Sciences Inc. stock fall even when earnings are good?

Yes. In 5 of the last 12 reports, Gilead Sciences Inc. fell on the earnings day despite growing EPS. Expectations already priced in, or guidance, can matter more than the reported numbers.

Does Gilead Sciences Inc. stock keep moving after the earnings day?

Over the last 12 reports, the move continued in the same direction for the following five trading days 33% of the time. This tendency is known as post-earnings announcement drift.